July 8, 2025 - News

WeightWatchers Rebrands for the Menopause Era

Back from the brink.
An older woman eating a salad

WeightWatchers is betting on women’s health.

The latest: Fresh out of bankruptcy, WeightWatchers is relisting on NASDAQ and repositioning as a women’s health company.

As part of its restructuring, WW named industry veteran Dr. Kim Boyd as chief medical officer, appointed a new board (including Eli Lilly’s former obesity chief), and announced a clinical program to support women through perimenopause, menopause, and beyond.

New playbook. The weight loss brand struggled to keep pace with GLP-1s, despite acquiring telehealth startup Sequence in 2023.Retooling, WW now plans to help women manage metabolic and life stage shifts with a mix of functional and clinical care, combining nutrition, coaching, community, and hormone therapies.

Still a primary driver, it’ll continue to prescribe weight loss meds, partneringwith Novo Nordisk following the drugmaker’s fallout with Hims & Hers.

White space. While 70% of women experience weight gain during menopause, few trusted brands offer integrated support.

As GLP-1s gain acceptance, WW is the latest entrant reframing weight loss as speciality whole-person care. Branching out, menopause care platform Midi Health added $60M and entered female-focused longevity, while Hims & Hers and Noom layer in HRT.

Punchline: WeightWatchers missed the GLP-1 boom. Trying to catch the next wave, it’s attempting to meet women where they are with hormone-aware, longevity-focused care.

Joe Vennare
Joe Vennare
linked in for author
The future of health and wellness in one newsletter

Subscribe for insights on the wellness economy, gyms and studios, preventative healthcare, wearable tech, and more

No thanks.